Message to Matthews Asia Innovative Growth Fund Shareholders
28 April 2023
We are pleased to announce that Inbok Song has been named a Co-Manager of the Matthews Asia Innovative Growth Fund. She joins a portfolio management team comprised of Lead Manager Michael Oh, CFA, and Co-Manager Taizo Ishida.
Inbok’s appointment as a Co-Manager formalizes her role and responsibilities on the Fund and deepens her relationship within the Asia Innovators team. Inbok is also a Lead Manager on the Matthews Pacific Tiger Fund and has significant knowledge of Asia markets and deep experience of researching innovative and technology companies that are closely aligned with the Matthews Asia Innovative Growth Fund’s investment universe.
We are very proud of the depth and diversity of the investment team that we have built at Matthews for over 30 years.
Thank you for your investment in Matthews Asia Funds.
Chief Executive Officer
|Robert Horrocks, PhD
Chief Investment Officer
The Fund is a sub-fund of Matthews Asia Funds SICAV, an umbrella fund, with segregated liability between sub-funds, established as an open-ended investment company with variable capital and incorporated with limited liability under the laws of Luxembourg. The current prospectus, Key Investor Information Document or Key Information Document, or other offering documents (“Offering Documents”) contain this and other information and can be obtained by visiting global.matthewsasia.com.
Investing in international and emerging markets may involve additional risks, such as social and political instability. Investing in international, emerging and frontier markets may involve additional risks, such as social and political instability, market illiquidity, exchange-rate fluctuations, a high level of volatility and limited regulation. Additionally, investing in emerging and frontier securities involves greater risks than investing in securities of developed markets, as issuers in these countries generally disclose less financial and other information publicly or restrict access to certain information from review by non-domestic authorities. Emerging and frontier markets tend to have less stringent and less uniform accounting, auditing and financial reporting standards, limited regulatory or governmental oversight, and limited investor protection or rights to take action against issuers, resulting in potential material risks to investors. Pandemics and other public health emergencies can result in market volatility and disruption.
It is the responsibility of any persons wishing to subscribe for shares to inform themselves of and to observe all applicable laws and regulations of any relevant jurisdictions. An investment in the Matthews Asia Funds is not available in all jurisdictions. The Fund’s shares may not be sold to citizens or residents of the United States or in any other state, country or jurisdiction where it would be unlawful to offer, solicit an offer for, or sell the shares. No securities commission or regulatory authority has in any way passed upon the merits of an investment in the Fund or the accuracy or adequacy of this information or the material contained herein or otherwise.
In the UK, this document is only made available to professional clients and eligible counterparties as defined by the Financial Conduct Authority (“FCA”). Under no circumstances should this document be forwarded to anyone in the UK who is not a professional client or eligible counterparty as defined by the FCA. Issued in the UK by Matthews Global Investors (UK) Limited (“Matthews Asia (UK)”), which is authorised and regulated by the FCA, FRN 667893. In Singapore, this document is available to, and intended for Institutional Investors under Section 304 of the Securities and Futures Act. It should not be circulated or distributed to the retail public in Singapore. This document has not been reviewed by the Monetary Authority of Singapore.